These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 12067805)
1. Telomerase inhibition and the future management of head-and-neck cancer. McCaul JA; Gordon KE; Clark LJ; Parkinson EK Lancet Oncol; 2002 May; 3(5):280-8. PubMed ID: 12067805 [TBL] [Abstract][Full Text] [Related]
2. Telomeres and telomerase as targets for cancer therapy. Zimmermann S; Martens UM Cell Mol Life Sci; 2007 Apr; 64(7-8):906-21. PubMed ID: 17310277 [TBL] [Abstract][Full Text] [Related]
3. Telomerase inhibitors for the treatment of cancer: the current perspective. Perry PJ; Arnold JR; Jenkins TC Expert Opin Investig Drugs; 2001 Dec; 10(12):2141-56. PubMed ID: 11772310 [TBL] [Abstract][Full Text] [Related]
4. Telomerase inhibitors as anticancer therapy. Akiyama M; Hideshima T; Munshi NC; Anderson KC Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724 [TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of telomerase activation and telomere length in head and neck cancer. Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related]
7. Telomere dysfunction is related to the intrinsic radio-resistance of human oral cancer cells. McCaul JA; Gordon KE; Minty F; Fleming J; Parkinson EK Oral Oncol; 2008 Mar; 44(3):261-9. PubMed ID: 17475542 [TBL] [Abstract][Full Text] [Related]
8. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects. Kelland LR Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745 [TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Mao L; El-Naggar AK; Fan YH; Lee JS; Lippman SM; Kayser S; Lotan R; Hong WK Cancer Res; 1996 Dec; 56(24):5600-4. PubMed ID: 8971162 [TBL] [Abstract][Full Text] [Related]
10. Telomerase inhibitors in cancer therapy: current status and future directions. Incles CM; Schultes CM; Neidle S Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225 [TBL] [Abstract][Full Text] [Related]